Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what steps his Department is taking to improve the availability of the drug Anakinra.

Anakinra is available for the treatment of patients in the United Kingdom, subject to decisions by the relevant commissioner. In the absence of guidance from the National Institute for Health and Care Excellence for this drug, it is for commissioners to make decisions based on an assessment of the available evidence and on an individual patient’s clinical circumstances.